Advise neomycin-sensitive patients to avoid the following antibiotics ... The following are safe ophthalmic preparations: Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox ...

On December 16, 2024, the U.S. Food and Drug Administration (FDA) announced a nationwide recall affecting 136,181 bottles of ...

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR ) and its oncology-focused subsidiary, Citius Oncology (Nasdaq: CTOR ), today announced significant progress in ...

The drug candidate is administered through oral route in the form of a tablet and through ophthalmic route as a solution and is an incrementally ... specialized pharmaceutical products, including ...

A complete ophthalmic examination was conducted for all patients ... Postoperatively, all patients were started on prophylactic antibiotic eye drops six times per day for 2 weeks, topical lubricating ...

Rural areas are increasingly facing ophthalmic subspecialty surgeon shortages, according to a study published online Jan. 2 in JAMA Ophthalmology.

Ophthalmic nonsteroidal anti-inflammatory ... Combination corticosteroid-antibiotic preparations, such as TobraDex ® (tobramycin 0.3%/dexamethasone 0.1%) (Alcon, Ft. Worth, TX), and Maxitrol ...

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no ...

Eye drops are the most preferred drug delivery method in the ophthalmic market, yet developing eye drop formulations targeting the retina, located in the posterior segment of the eye, remains a ...

The global ophthalmic sprays market, valued at USD 343 million in 2023, is projected to experience exponential growth, ...

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.

With the push of a button, the BSIDx identifies disease-causing organisms and performs antibiotic susceptibility testing from positive blood cultures, in under 5 hours. In a head-to-head race ...